Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough To Switch?
Medical professionals look to biosimilar drugs as a way to increase competition and give consumers cheaper options, but doctors and patients are raising concerns.
biosimilar
Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
Europeans have found the secret to making some of the world’s costliest medicines much more affordable, as much as 80 percent cheaper than in the U.S.
